Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Explore why a budget calculator may be inaccurate and how to diagnose common sources of error, then implement corrective steps.
19,411 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
When a CEO puts real money behind his own company’s stock, investors sit up and take notice. This article breaks down...
Investors sent shares of National Energy Services Reunited higher after news of sizable cementing contracts in the Mi...
Disney delivered a strong quarter that sent its stock higher. This article breaks down the earnings, the drivers behi...
New market data shows most active managers fail to beat the S&P 500 over extended periods. This story explains the fo...
June volatility has weighed on semiconductor stocks, but a window is emerging for selective buys. Here are three name...
When spacex officially joined nasdaq-100, investors expected a jump in demand. Instead, the stock price moved lower a...
Trilogy Metals has fallen hard this week, leaving investors asking whether the downturn is a short-lived pullback or ...
As 2026 unfolds, a value-led rotation is drawing fresh money into the Vanguard Value ETF (VTV). With inflation coolin...
Two powerhouse energy stocks could shape the next decade. This guide explains why NextEra Energy and GE Vernova fit a...
A notable move in a clean energy ETF raised questions: does a big sale signal trouble or discipline in a fast-growing...
A new AI-driven supercycle is unfolding, but you don’t need to chase dramatic bets. This guide explains how agentic A...